Treatment-resistant schizophrenia : the relationship between clozapine plasma concentration and clinical outcome

被引:0
|
作者
Kammoun, I. [1 ]
Jouini, R. [2 ,3 ]
Aissa, A. [1 ]
Boukhchina, R. [1 ]
Zgueb, Y. [1 ]
Khelifa, E. [3 ]
Ouali, U. [1 ]
Jomli, R. [1 ]
Nacef, F. [1 ]
El Hechmi, Z. [3 ]
机构
[1] Razi Hosp, Psychiat Dept A, Manouba, Tunisia
[2] Razi Hosp, Psychiat F, Manouba, Tunisia
[3] Razi Hosp, Psychiat Dept F, Manouba, Tunisia
关键词
treatment-resistant schizophrenia; clozapine; clozapine plasma concentration;
D O I
10.1192/j.eurpsy.2022.2039
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
EPV1408
引用
收藏
页码:S789 / S789
页数:1
相关论文
共 50 条
  • [41] Side effects of clozapine in older adults with treatment-resistant schizophrenia compared to younger adults
    Groenewald, Floor C. E.
    Kok, Rob M.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2024, 39 (01)
  • [42] Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia
    Sanguesa, Estela
    Fernandez-Egea, Emilio
    Concha, Julia
    Garcia, Cristina B.
    Ribate, Maria Pilar
    BIOMEDICINES, 2024, 12 (03)
  • [43] Electroconvulsive therapy or clozapine for adolescents with treatment-resistant schizophrenia: an explorative analysis on symptom dimensions
    Tuncturk, Mustafa
    Ermis, Cagatay
    Buyuktaskin, Dicle
    Turan, Serkan
    Saglam, Yesim
    Alarslan, Sezen
    Guler, Duru
    Sut, Ekin
    Unutmaz, Guldal
    Guzel, Ayse Beste
    Canbek, Ozge Atay
    Inal, Neslihan
    Karacetin, Gul
    Hazell, Philip
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2023, 27 (03) : 257 - 263
  • [44] Treatment-resistant schizophrenia.
    Lublin, H
    NORDIC JOURNAL OF PSYCHIATRY, 1997, 51 : 9 - 23
  • [45] Effectiveness of clozapine on quality of life and functioning in patients with treatment-resistant schizophrenia
    Verma, Meha
    Grover, Sandeep
    Chakrabarti, Subho
    NORDIC JOURNAL OF PSYCHIATRY, 2021, 75 (02) : 135 - 144
  • [46] Risperidone versus clozapine in treatment-resistant schizophrenia:: A randomized pilot study
    Wahlbeck, K
    Cheine, M
    Tuisku, K
    Ahokas, A
    Joffe, G
    Rimón, R
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (06) : 911 - 922
  • [47] Clozapine prescribing barriers in the management of treatment-resistant schizophrenia A systematic review
    Baig, Anum Iqbal
    Bazargan-Hejazi, Shahrzad
    Ebrahim, Gul
    Rodriguez-Lara, Jaziel
    MEDICINE, 2021, 100 (45)
  • [48] Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment
    Yamamori, Hidenaga
    Hashimoto, Ryota
    Fujita, Yuko
    Numata, Shusuke
    Yasuda, Yuka
    Fujimoto, Michiko
    Ohi, Kazutaka
    Umeda-Yano, Satomi
    Ito, Akira
    Ohmori, Tetsuro
    Hashimoto, Kenji
    Takeda, Masatoshi
    NEUROSCIENCE LETTERS, 2014, 582 : 93 - 98
  • [49] Feasibility and Effect of Increasing Clozapine Plasma Levels in Long-Stay Patients With Treatment-Resistant Schizophrenia
    Bogers, Jan P. A. M.
    Schulte, Peter F. J.
    Broekman, Theo G.
    de Haan, Lieuwe
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2023, 43 (02) : 97 - 105
  • [50] Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
    Agid, Ofer
    Crespo-Facorro, Benedicto
    de Bartolomeis, Andrea
    Fagiolini, Andrea
    Seppala, Niko
    Howes, Oliver D.
    Correll, Christoph U.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2024, 84 : 35 - 47